A study to find out more about prostate cancer (ReIMAGINE Prostate Cancer Risk)
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
Cancer type:
Prostate cancer
Status:
Closed
Phase:
Other
This study is collecting samples to carry out detailed testing in men having tests for suspected prostate cancer.
More about this trial
Researchers know that 1 in 3 men over the age of 50 have cancer cells in their prostate. But most will never know they have cancer and it won’t affect their quality of life 
or how long they live. But in some men, the cancer can grow quickly. These cancers are more likely to spread outside of the prostate.
or how long they live. But in some men, the cancer can grow quickly. These cancers are more likely to spread outside of the prostate.At the moment there isn’t a way to tell the difference between prostate cancer that grows fast and those that grow slowly. So researchers are running this study to find out more. To do this, they plan to look at:
- tissue samples (
biopsies ) from the prostate - urine samples
- blood samples
- detailed images from scans
They’ll carry out very detailed testing on these. They want to find out more about:
- how prostate cancer develops
- why some prostate cancers spread to other parts of the body and others don’t
- why treatment works for some prostate cancers and not for others
Researchers hope this could improve the diagnosis and monitoring of prostate cancer.
Please note, there won’t be a direct benefit if you take part in this study. But it might help other men with prostate cancer in the future.
Who can enter
The following bullet points list the entry conditions for this study. Talk to your doctor or the study team if you are unsure about any of these. They will be able to advise you.
Who can take part
You may be able to join this study if all of the following apply.
- You have a PSA blood test result of 20 or less and you had this test done in the last 3 months.
- You have had an
MRI scan of your prostate. - The MRI scan shows a suspicious area that needs a prostate biopsy to confirm whether or not cancer there is cancer.
- You haven’t had hormone therapy in the last 6 months.
Who can’t take part
You cannot join this study if any of these apply.
You:
- can’t donate tissue, blood or urine samples
- have already had treatment for prostate cancer including surgery, radiotherapy, chemotherapy, focal therapy such as HIFU, cryotherapy, Nanoknife or
radiofrequency ablation, or other drug treatments - had a prostate biopsy less than 12 months before your MRI scan
Trial design
This study is taking place in the UK. The researchers need 1,000 men to join.
The study team might approach you:
- when you are referred to hospital by your GP
- on the day of your prostate MRI
- after you have had an MRI scan and the doctors advise you to have a prostate biopsy
They’ll give you an information sheet about the study. But they’ll only invite you to join if the MRI recommends, and you decide to have a prostate biopsy. This isn’t an extra test. You have this even if you decide you don’t want to join the study.
Research samples
The doctors or study team will ask permission to collect 3 extra tissue samples when you have the biopsy. You also give blood and urine samples as well as access to medical information including images from your MRI scan. They plan to use the samples to look at bits of genetic material (DNA ).
).They’ll compare samples from men with and without prostate cancer to try and find out what plays a part in cancer developing.
They might also look for other genetic changes in the blood. They’ll tell you about any results that are important for you and your family if they find anything. If this is what you have agreed to beforehand.
Hospital visits
You shouldn’t need any extra hospital visits as a result of taking part in this study.
Follow up
The study team will follow you up for a long period of time if you agree. You won’t have any extra hospital visits. They’ll check your medical notes and records to see how you are getting on. This will help researchers to understand more about the long term outcomes of men with prostate cancer
Side effects
The study team are taking a few extra tissue samples from the prostate. You may have an increased:
- risk of bleeding or infection
- bruising of the skin
But these side effects are short term.
We have more information about tests to diagnose prostate cancer.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Chief Investigator
Prof Hashim Ahmed
Prof Mark Emberton
Supported by
Cancer Research UK (CRUK)
Medical Research Council (MRC)
University College London (UCL)
Imperial College London (ICL)
Kings College London (KCL)
Other information
The study team have made a short video about taking part in ReIMAGINE: https://www.reimagine-pca.org/patients
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040
Last review date
CRUK internal database number:
16321
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
